Marinus Pharmaceuticals Inc MRNS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:23 PM EDT
1.41quote price arrow up+0.06 (+4.44%)
Volume
19,797
Close
1.35quote price arrow up+0.02 (+1.50%)
Volume
1,286,058
52 week range
1.11 - 11.26
Loading...
  • Open1.36
  • Day High1.36
  • Day Low1.27
  • Prev Close1.33
  • 52 Week High11.26
  • 52 Week High Date01/08/24
  • 52 Week Low1.11
  • 52 Week Low Date04/16/24

Key Stats

  • Market Cap74.161M
  • Shares Out54.93M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-87.58

KEY STATS

  • Open1.36
  • Day High1.36
  • Day Low1.27
  • Prev Close1.33
  • 52 Week High11.26
  • 52 Week High Date01/08/24
  • 52 Week Low1.11
  • 52 Week Low Date04/16/24
  • Market Cap74.161M
  • Shares Out54.93M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-87.58

RATIOS/PROFITABILITY

  • EPS (TTM)-2.64
  • P/E (TTM)-0.51
  • Fwd P/E (NTM)-0.64
  • EBITDA (TTM)-133.818M
  • ROE (TTM)-449.93%
  • Revenue (TTM)28.288M
  • Gross Margin (TTM)91.22%
  • Net Margin (TTM)-513.80%
  • Debt To Equity (MRQ)-447.08%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Marinus Pharmaceuticals Inc

 

Profile

MORE
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of ZTALMY oral suspension CV for the treatment of seizures associated with...
Scott Braunstein M.D.
Chairman of the Board, President, Chief Executive Officer
Steven Pfanstiel
Chief Financial Officer, Chief Operating Officer, Treasurer
Address
Three Radnor Corporate Center
100 Matsonford Rd, Suite 304
Radnor, PA
19087
United States

Top Peers

SYMBOLLASTCHG%CHG
ACRS
Aclaris Therapeutics Inc
1.19UNCHUNCH
ATRA
Atara Biotherapeutics Inc
0.71+0.10+16.3934%
TKNO
Alpha Teknova Inc
1.79UNCHUNCH
PRE
Prenetics Global Ltd
5.89+0.09+1.48%
AADI
Aadi Bioscience Inc
1.86-0.05-2.62%